Results 1 to 5 of 35

PTAB Denies IPR Challenging Patent Relating to a Prenatal Vitamin

USA - November 22 2022 In Westminster Pharmaceuticals, LLC, v. LPRI France, the Patent Trial and Appeal Board found that Westminster did not show that it would likely…

Jordan M. Gringauz, Thomas L. Irving, Stacy Lewis, Amanda K. Murphy

Product-by-Process Construction Dooms Claims

USA - November 21 2022 In Kamstrup A/S v. Axioma Metering UAB, No. 2021-1923 (Fed. Cir. Aug. 12, 2022) (“Kamstrup”), the Court of Appeals for the Federal Circuit affirmed…

Thomas L. Irving, Stacy Lewis, Amanda K. Murphy, Caitlin E. O’Connell

Updated PTAB guidance on use of applicant admitted prior art in IPRs

USA - November 4 2022 Following the Federal Circuit's decision in Qualcomm Inc. v. Apple Inc., 24 F.4th 1367 (Fed. Cir. 2022), on June 9, 2022, the USPTO Director…

Yinan Liu, Amanda K. Murphy

The CCPA’s Lasting Impact on U.S. Patent Law - An Examination of CCPA Enablement Decisions

USA - November 4 2022 The enablement requirement is a bedrock principle of the U.S. patent system. In exchange for a 20-year monopoly on a claimed invention, the public…

Thomas L. Irving, Stacy Lewis

Want to Avoid Having Your Complaint Dismissed? Plead It with Sufficient Particularity and Don’t Take Positions Contrary to What You Told PTAB

USA - October 3 2022 When attempting to bring an early end to a litigation, a defendant may have several options, such as filing a motion to dismiss for failure to state…

Kathleen Hanley, Thomas L. Irving, Stacy Lewis, Amanda K. Murphy